Improved precision of tissue margin orientation can reduce local recurrence rates. Annals of Surgical Oncology

"Standardized and reproducible methods of margin evaluation must be developed."
New England Journal of Medicine
 
"The person in the best position to mark the orientation of the specimen is clearly the surgeon. Inking of the specimen is best and most accurate when the surgeon in the operating room performs it." 
American Society of Breast Disease 

Benefits of MarginMarker

Accurate
Orientation and re-excisions are more accurate because complete margins of the specimen are defined and marked, resulting in fewer unnecessary reexcisions and lower cancer recurrence
 

Safe
Eliminates puncture risk associated with current suture based methods of orientation
 

Efficient
Saves 3-4 minutes per case
Provides a platform for standardization of orientation procedures
 

Easy
Improves communication between the surgeon and pathologist

Applications

General and Oncological Surgeons can use MarginMarker for breast, liver, lip, anus, colon, ovary, uterus, labia and soft tissue cancer surgery.

Plastic, ENT, and Dermatological surgeons can use MarginMarker for basal skin cancer, squamous cell carcinoma, and melanoma cancer procedures.

MarginMarker is a sterile single use ink device that the surgeon uses in the operating room to orient excised tissue.  Using MarginMarker, the surgeon applies ink to the excised tissue. Rather than identifying just a point in space, as suture does, MarginMarker identifies each entire plane, creating a more accurate designation of original orientation than sutures can attain.  MarginMarker includes labels indicating to pathology the color associated with each direction, tools to apply the ink and fixative to ensure the ink adheres securely. 

MarginMarker is available in six colors or three colors.  The ink colors and orientations can be customized to your specifications.   

MarginMarker's  inks are identical to those currently used in pathology labs, and do not interfere with any aspects of processing or analysis conducted at the pathology labs. 

MarginMarker is patent pending.